RT Journal Article
SR Electronic
T1 Sex and aging signatures of proteomics in human cerebrospinal fluid identify distinct clusters linked to neurodegeneration
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.18.24309102
DO 10.1101/2024.06.18.24309102
A1 Seo, Dahun
A1 Lee, Cheolmin Matthew
A1 Apio, Catherine
A1 Heo, Gyujin
A1 Timsina, Jigyasha
A1 Kohlfeld, Pat
A1 Boada, Merce
A1 Orellana, Adelina
A1 Fernandez, Maria Victoria
A1 Ruiz, Agustin
A1 Morris, John C.
A1 Schindler, Suzanne E.
A1 Park, Taesung
A1 Cruchaga, Carlos
A1 Sung, Yun Ju
YR 2024
UL http://medrxiv.org/content/early/2024/06/19/2024.06.18.24309102.abstract
AB Sex and age are major risk factors for chronic diseases. Recent studies examining age-related molecular changes in plasma provided insights into age-related disease biology. Cerebrospinal fluid (CSF) proteomics can provide additional insights into brain aging and neurodegeneration. By comprehensively examining 7,006 aptamers targeting 6,139 proteins in CSF obtained from 660 healthy individuals aged from 43 to 91 years old, we subsequently identified significant sex and aging effects on 5,097 aptamers in CSF. Many of these effects on CSF proteins had different magnitude or even opposite direction as those on plasma proteins, indicating distinctive CSF-specific signatures. Network analysis of these CSF proteins revealed not only modules associated with healthy aging but also modules showing sex differences. Through subsequent analyses, several modules were highlighted for their proteins implicated in specific diseases. Module 2 and 6 were enriched for many aging diseases including those in the circulatory systems, immune mechanisms, and neurodegeneration. Together, our findings fill a gap of current aging research and provide mechanistic understanding of proteomic changes in CSF during a healthy lifespan and insights for brain aging and diseases.Competing Interest StatementCC has received research support from: GSK and EISAI. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of Circular Genomics and owns stocks.Funding StatementThis work was supported by grants from the National Institutes of Health, RF1 AG074007 (YJS), R01 AG044546 (CC), P01 AG003991 (CC), RF1 AG053303 (CC), RF1 AG058501 (CC), U01 AG058922 (CC), P30 AG066444 (JCM), P01 AG003991 (JCM), P01 AG026276 (JCM), and the Chan Zuckerberg Initiative (CZI), the Michael J. Fox Foundation (CC), and the Alzheimer Association Zenith Fellows Award (ZEN-22-848604, awarded to CC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for every individual cohort was obtained from the respective Institutional Review Boards and research was carried out in accordance with the approved protocols (WUSTL IRB approval 201109148). Written informed consent was obtained from participants or their family members and all participating institutions approved the study design.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data generated in this study are included in this published article.